PGHL — Procter & Gamble Health Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹83.25bn
- IN₹81.40bn
- IN₹14.08bn
Annual cashflow statement for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 9 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,534 | 3,142 | 2,733 | 3,116 | 4,499 |
| Depreciation | |||||
| Non-Cash Items | 2.3 | 134 | 249 | -44.9 | -84.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,112 | -1,197 | -973 | -1,551 | -1,273 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,695 | 2,360 | 2,283 | 1,687 | 3,378 |
| Capital Expenditures | -379 | -425 | -217 | -85.6 | -155 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 124 | 210 | 149 | 182 | 168 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -255 | -215 | -68.7 | 95.9 | 12.6 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,886 | -985 | -4,181 | -2,347 | -3,439 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,446 | 1,160 | -1,967 | -565 | -48.7 |